LINDSAY RECK: Open Payments
NPI 1912453416 · AUSTIN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,958 in 229 payments from 24 companies in 2025. Trend: 2023 $4,740 · 2024 $4,719 · 2025 $3,958
Food & beverage: $3,803Education: $155
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 40 | $697 |
| Janssen Biotech, Inc. | 35 | $575 |
| UCB, Inc. | 12 | $404 |
| Arcutis Biotherapeutics, Inc. | 15 | $264 |
| Novartis Pharmaceuticals Corporation | 16 | $259 |
| GENZYME CORPORATION | 12 | $232 |
| Galderma Laboratories, L.P. | 32 | $209 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 6 | $177 |
| Organon LLC | 6 | $154 |
| Regeneron Healthcare Solutions, Inc. | 11 | $144 |
Products named: TREMFYA, DUPIXENT, RINVOQ, Bimzelx, Zoryve, SKYRIZI, COSENTYX, VTAMA.
Industry payments across TX — which companies pay providers there.
